BIO
Price
$242.21
Change
-$7.53 (-3.02%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
9.79B
4 days until earnings call
MTD
Price
$1061.79
Change
-$13.21 (-1.23%)
Updated
Apr 25 closing price
Capitalization
28.69B
4 days until earnings call
Ad is loading...

BIO vs MTD

Header iconBIO vs MTD Comparison
Open Charts BIO vs MTDBanner chart's image
Bio-Rad Laboratories
Price$242.21
Change-$7.53 (-3.02%)
Volume$880
Capitalization9.79B
Mettler-Toledo International
Price$1061.79
Change-$13.21 (-1.23%)
Volume$165.72K
Capitalization28.69B
BIO vs MTD Comparison Chart
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. MTD commentary
Apr 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and MTD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 27, 2025
Stock price -- (BIO: $249.74 vs. MTD: $1075.00)
Brand notoriety: BIO and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 57% vs. MTD: 143%
Market capitalization -- BIO: $9.79B vs. MTD: $28.69B
BIO [@Medical Specialties] is valued at $9.79B. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, MTD is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 5 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 5 bullish, 3 bearish.
  • MTD’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both BIO and MTD are a good buy in the short-term.

Price Growth

BIO (@Medical Specialties) experienced а +4.85% price change this week, while MTD (@Medical Specialties) price change was +6.97% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.64%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was -1.57%.

Reported Earning Dates

BIO is expected to report earnings on Jul 24, 2025.

MTD is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+4.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($28.7B) has a higher market cap than BIO($9.79B). MTD has higher P/E ratio than BIO: MTD (37.36) vs BIO (3.64). MTD YTD gains are higher at: -12.150 vs. BIO (-23.978). MTD has higher annual earnings (EBITDA): 1.17B vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. MTD (69.8M). BIO has less debt than MTD: BIO (1.41B) vs MTD (2.08B). MTD has higher revenues than BIO: MTD (3.79B) vs BIO (2.67B).
BIOMTDBIO / MTD
Capitalization9.79B28.7B34%
EBITDA-654.76M1.17B-56%
Gain YTD-23.978-12.150197%
P/E Ratio3.6437.3610%
Revenue2.67B3.79B71%
Total Cash1.61B69.8M2,302%
Total Debt1.41B2.08B68%
FUNDAMENTALS RATINGS
BIO vs MTD: Fundamental Ratings
BIO
MTD
OUTLOOK RATING
1..100
1567
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
10059
SMR RATING
1..100
953
PRICE GROWTH RATING
1..100
6465
P/E GROWTH RATING
1..100
7976
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIO's Valuation (80) in the Medical Specialties industry is in the same range as MTD (97). This means that BIO’s stock grew similarly to MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (59) in the Medical Specialties industry is somewhat better than the same rating for BIO (100). This means that MTD’s stock grew somewhat faster than BIO’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for BIO (95). This means that MTD’s stock grew significantly faster than BIO’s over the last 12 months.

BIO's Price Growth Rating (64) in the Medical Specialties industry is in the same range as MTD (65). This means that BIO’s stock grew similarly to MTD’s over the last 12 months.

MTD's P/E Growth Rating (76) in the Medical Specialties industry is in the same range as BIO (79). This means that MTD’s stock grew similarly to BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOMTD
RSI
ODDS (%)
Bullish Trend 6 days ago
69%
Bullish Trend 6 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
70%
Bullish Trend 6 days ago
69%
Momentum
ODDS (%)
Bullish Trend 6 days ago
66%
N/A
MACD
ODDS (%)
Bullish Trend 6 days ago
74%
N/A
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
64%
Bearish Trend 6 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
67%
Bearish Trend 6 days ago
64%
Advances
ODDS (%)
Bullish Trend 14 days ago
69%
Bullish Trend 14 days ago
62%
Declines
ODDS (%)
Bearish Trend 7 days ago
66%
Bearish Trend 7 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
59%
Bullish Trend 6 days ago
76%
Aroon
ODDS (%)
Bearish Trend 6 days ago
66%
Bearish Trend 6 days ago
63%
View a ticker or compare two or three
Ad is loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been loosely correlated with RGEN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BIO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+0.36%
RGEN - BIO
61%
Loosely correlated
+2.71%
TMO - BIO
60%
Loosely correlated
-1.15%
WAT - BIO
59%
Loosely correlated
+1.74%
A - BIO
59%
Loosely correlated
+1.92%
MTD - BIO
57%
Loosely correlated
+2.75%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with WAT. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
+2.75%
WAT - MTD
70%
Closely correlated
+1.74%
RVTY - MTD
66%
Loosely correlated
+1.55%
TMO - MTD
64%
Loosely correlated
-1.15%
A - MTD
63%
Loosely correlated
+1.92%
BIO - MTD
57%
Loosely correlated
+0.36%
More